Former U.S. Congressman Fattah Calls for African Brain Research Fund During Global Neuroscience Conference
28 oct. 2021 17h57 HE
|
Fattah Neuroscience Global Advisors
Accra, Ghana / Philadelphia, PA, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Today, former United States Congressman and CEO of Fattah Neuroscience Global Advisors, Chaka Fattah, delivered a powerful virtual...
Nexstim’s SmartFocus® TMS Technology Used in Award-Winning Project Addressing Disorders of Consciousness after Severe Brain Injury
15 oct. 2021 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 15 October 2021 at 9 AM (EEST) Nexstim’s SmartFocus® TMS Technology Used in Award-Winning Project Addressing Disorders of Consciousness after Severe Brain Injury Nexstim Plc...
Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds
10 sept. 2021 07h00 HE
|
COMPASS Pathfinder Ltd.
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has engaged Hamilton Morris,...
Danielle Schlosser joins COMPASS Pathways from Verily Life Sciences to lead clinical innovation and therapist training
21 juil. 2021 07h00 HE
|
COMPASS Pathfinder Ltd.
London, UK – 21 July 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
Ischemix, Inc. Receives US Department of Defense Funding of $2.9 million to Conduct Phase 1 Study of Drug Candidate to Treat Traumatic Brain Injury (TBI)
07 juil. 2021 12h51 HE
|
Ischemix, Inc.
GRAFTON, Mass., July 07, 2021 (GLOBE NEWSWIRE) -- Ischemix, Inc., a private company focused on developing therapeutics for serious medical conditions, today announced that the US Department of...
COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme
23 juin 2021 07h00 HE
|
COMPASS Pathfinder Ltd.
Programme aims to support students from under-represented ethnic groups London, UK – 23 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to...
Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum
29 avr. 2021 07h00 HE
|
Trevena Inc.
CHESTERBROOK, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central...
Sensory Challenges and Anxiety in Children with and without Autism - A Free Webinar from the Brain & Behavior Research Foundation
02 mars 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, March 02, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Sensory Challenges and Anxiety in Children with and without Autism” on...
Novartis Entresto® granted expanded indication in chronic heart failure by FDA
16 févr. 2021 13h23 HE
|
Novartis International AG
Entresto is the first and only therapy approved in the US to treat patients diagnosed with guideline-defined heart failure to include both those with heart failure with reduced ejection fraction...
Bux Pain Management Treats First Commercial Patient in the Nation Using Spark Biomedical’s Sparrow Therapy System
03 févr. 2021 15h34 HE
|
Spark Biomedical
Danville, KY, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Dr. Anjum Bux, a leading expert in pain management, was the first in the nation to successfully treat commercial patients using Transcutaneous...